Manufacturing
Navigate forward to interact with the calendar and select a date. Press the question mark key to get the keyboard shortcuts for changing dates.
Navigate backward to interact with the calendar and select a date. Press the question mark key to get the keyboard shortcuts for changing dates.
As nations engage in a race for global advantage in innovation, ITIF champions a new policy paradigm that ensures businesses and national economies can compete successfully by spurring public and private investment in foundational areas such as research, skills, and 21st century infrastructure. Our research on manufacturing policy examines current trends and encouraging continued innovation in the manufacturing sector through increased public and private investment.
Vice President, Global Innovation Policy, and Director, Center for Life Sciences Innovation
Information Technology and Innovation Foundation
Read BioFeatured
Computer Chips vs. Potato Chips: The Case for a U.S. Strategic-Industry Policy
With the rise of China, the United States needs more than a competitiveness strategy; it needs a policy specifically tailored to boost production and innovation capacity in strategically important industries—especially technologically sophisticated ones with dual-use capabilities.
More Publications and Events
April 30, 2026|Events
Strengthening America’s Edge in Priority Technologies of the 21st Century
Please join ITIF for a virtual panel featuring authors of a new book by MIT Press, Priority Technologies: Ensuring US Security and Shared Prosperity. Experts will discuss how to strengthen U.S. innovation and industrial ecosystems and which priority technologies will be critical to long-term global economic, military, and technological leadership in the decades ahead.
April 6, 2026|Blogs
Fact of the Week: One in Ten Cars Sold in Europe in December 2025 Was Chinese
Sales of Chinese hybrids and plug-in hybrids in Europe increased by a factor of 14 between August 2024 and August 2025
April 3, 2026|Blogs
Trump Pharma Tariffs: Wrong Rx for U.S. Patients, Manufacturing, and Innovation
The Trump administration’s Section 232 pharmaceutical tariffs will needlessly raise drug costs, harm U.S. patients, and undermine both domestic manufacturing and global biopharmaceutical innovation, while better policy options exist to strengthen the industry without these damaging side effects.
March 23, 2026|Reports & Briefings
Assessing the Evolving Global Competitiveness of the US Auto Industry
To win the techno-economic competition with China, America must be able to assess the factors impacting the global competitiveness of its advanced-technology industries. Using the auto industry as a template, U.S. competitiveness has faltered considerably.
March 23, 2026|Blogs
Fact of the Week: The CHIPS and Science Act Generated About 15,000 Direct Jobs in Affected Counties
A report estimates that in the 149 American counties that had semiconductor activity prior to the passage of the U.S. Innovation and Competitiveness Act (USICA), the precursor bill to the CHIPS Act, employment increased by 110 jobs per county, equivalent to a 12.7 percent increase in employment.
March 9, 2026|Blogs
Fact of the Week: Productivity in the Pharmaceutical and Medicine Industry Fell by 2.4 Percent Annually Between 2014 and 2024
The pharmaceutical and medicine industry has seen its productivity decline by 2.4 percent annually between 2014 and 2024, one of the worst performances among U.S. manufacturing industries.
February 23, 2026|Reports & Briefings
Internal Value Chains Remain Dependent on China Even as Multinationals Shift Production to America
Advanced manufacturers based in East Asia are expanding investment into the U.S. economy. Yet, many of their internal value chains remain anchored in China, giving the PRC significant leverage over U.S. interests. U.S. policymakers should respond both defensively and offensively.
January 30, 2026|Blogs
Fact of the Week: Chinese Ship Exports Have Increased by 1,525 Percent Since 2004
The Chinese shipbuilding industry controls 55 percent of global market share, with exports increasing by 1,525 percent since 2004.
January 29, 2026|Blogs
The Case Against Allowing Chinese Factories in America
Letting Chinese EV and battery firms build in America wouldn’t revive manufacturing. It would reduce U.S. market share, hollow out domestic capabilities, and create new strategic dependencies.
January 17, 2026|Blogs
Cars, Canola, and the Country Canada Chooses to Be
Treating cars like canola is not strategy. Using industrial platforms as bargaining chips for commodity access risks locking Canada into a permanently resource-heavy economic structure, one in which manufacturing capacity cannot be easily rebuilt and its absence reshapes the economy for decades.
